Psilocybin rTMS for Treatment Resistant Depression
Phase 2
100
about 6 years
22–65
1 site in TX
About this study
This trial is testing whether giving psilocybin after a short, brain stimulation treatment (aiTBS) can help people with depression that hasn't responded to other treatments. The goal is to see if this combination is safe and works.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Low-dose psilocybin
- 2.Take Psilocybin
- 3.Use Accelerated intermittent theta burst (aiTBS) rTMS treatment
- +1 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
oral
Primary: Montgomery Asberg Depression Rating Scale (MADRS)
Secondary: Beck Depression Inventory II (BDI II), Columbia-Suicide Severity Rating Scale (C-SSRS), Discontinuation Emergent Signs and Symptoms Scale, Generalized Anxiety Disorder 7 (GAD-7), Mood and Anxiety Symptom Questionnaire 30 item Anhedonic Depression subscale (MASQ-30), Mood and Anxiety Symptom Questionnaire 30 item Anxious Arousal subscale (MASQ-30), Physicians Health Questionnaire 9 (PHQ-9), Quick Inventory of Depressive Symptom Self-Report (QIDS-SR)
therapeutic
Psychiatry / Mental Health